1. News | 2024.04.08

   Interested in helping to shape the Institut Pasteur of tomorrow? We're open to ideas!

   We invite you to join our discussion group on the image and perception of the Institut Pasteur to hear your opinion and suggestions.

2. News | 2023.06.06

   HIV-AIDS: natural killer cells that target HIV

   African green monkeys are able to live while being infected with the simian immunodeficiency virus (SIV) without ever developing AIDS. Their hint? Directly eliminate infected cells, without causing an inflammatory reaction that the virus could use to its advantage.

3. News | 2023.09.05

   HIV-AIDS: broadly neutralizing antibodies, stars of the lab

   Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...

4. News | 2023.07.10

   HIV-AIDS: a virus master of evasion

   Developing effective therapeutic vaccines requires knowing how to chemically recognize microbes, as well as exposing them to treatment. Able to mutate very quickly and to camouflage itself inside the cells it infects, the AIDS virus (or HIV) constitutes a challenge for researchers.

5. News | 2023.01.12

   Improving our understanding of insect vectors to curb disease outbreaks

   A few weeks after the book Le moustique, ennemi public n°1? , published by Quae, Anna-Bella Failloux, researcher at the Institut Pasteur and co-author of the book, looks back on the Pasteurian expertise on vector-borne diseases.

6. News | 2022.09.26

   Acerola: beware of potential allergic reactions

   Acerola is a tropical fruit sold as an OTC health and wellness product for its high vitamin C and antioxidant content. However, it also appears to contain allergenic compounds comparable to those found in some types of pollen and nuts. Juice and some food supplements made with this fruit may also contain these compounds. 

7. News | 2022.07.22

   Cryptococcal meningitis: a new effective treatment with fewer side effects

   A large-scale clinical trial has demonstrated the efficacy of a new therapeutic protocol to treat cryptococcal meningitis associated with HIV infection and shown that it leads to fewer adverse effects.

8. Fiche maladie | 2021.07.22

   Lyme disease (Lyme borreliosis)

   Lyme disease, also known as Lyme borreliosis, is a tick-borne disease. It is the most widespread vector-borne disease in the entire northern hemisphere. Its incidence continues to rise at global level as a result of demographic and environmental factors, including climate change.

9. Fiche maladie | 2021.07.07

   Buruli Ulcer

   Buruli ulcer is a disease caused by a bacterium that multiplies in skin and is currently reported in 33 countries, mostly in tropical regions. Although not fatal, it can lead to permanent disabilities, imposing a heavy burden on both patients and society.

10. News | 2023.10.09

    Gender equality: unequal visibility for men and women at scientific conferences

    Scientific conferences are an opportunity for early career scientists to develop their careers. But in a study combining sociology and quantitative analysis, scientists demonstrate that participants' success can be influenced by their gender.

Pages